All Stories

  1. Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

    Article • Expert Review of Gastroenterology & Hepatology, August 2019, Taylor & Francis

    Shereen Abdel Alem, Aisha Elsharkawy , Yehia El Shazly, Mohamed El Kassas, dina ziada

  2. DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV

    Article • Expert Review of Gastroenterology & Hepatology, May 2019, Taylor & Francis

    Dr Heba Omar, Shereen Abdel Alem, Aisha Elsharkawy , Dr Walid Kamal Ibrahim

  3. Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort

    Article • Journal of Medical Virology, May 2018, Wiley

    Shereen Abdel Alem

  4. Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon

    Article • Journal of Gastroenterology and Hepatology, August 2017, Wiley

    Aisha Elsharkawy , Shereen Abdel Alem

  5. Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience

    Article • Journal of Medical Virology, August 2017, Wiley

    Aisha Elsharkawy , Shereen Abdel Alem